218 related articles for article (PubMed ID: 27982704)
1. Tramadol, an Opioid Receptor Agonist: An Inhibitor of Growth, Morphogenesis, and Biofilm Formation in the Human Pathogen, Candida albicans.
Kathwate GH; Karuppayil SM
Assay Drug Dev Technol; 2016 Dec; 14(10):567-572. PubMed ID: 27982704
[TBL] [Abstract][Full Text] [Related]
2. Protocol for Determination of the Persister Subpopulation in Candida Albicans Biofilms.
De Brucker K; De Cremer K; Cammue BP; Thevissen K
Methods Mol Biol; 2016; 1333():67-72. PubMed ID: 26468100
[TBL] [Abstract][Full Text] [Related]
3. Antiepileptic Drugs Inhibit Growth, Dimorphism, and Biofilm Mode of Growth in Human Pathogen Candida albicans.
Kathwate GH; Shinde RB; Karuppayil SM
Assay Drug Dev Technol; 2015; 13(6):307-12. PubMed ID: 26241210
[TBL] [Abstract][Full Text] [Related]
4. β-Asarone, an active principle of Acorus calamus rhizome, inhibits morphogenesis, biofilm formation and ergosterol biosynthesis in Candida albicans.
Rajput SB; Karuppayil SM
Phytomedicine; 2013 Jan; 20(2):139-42. PubMed ID: 23123225
[TBL] [Abstract][Full Text] [Related]
5. Synergistic activity of lysozyme and antifungal agents against Candida albicans biofilms on denture acrylic surfaces.
Samaranayake YH; Cheung BP; Parahitiyawa N; Seneviratne CJ; Yau JY; Yeung KW; Samaranayake LP
Arch Oral Biol; 2009 Feb; 54(2):115-26. PubMed ID: 19038377
[TBL] [Abstract][Full Text] [Related]
6. Effect of filamentation and mode of growth on antifungal susceptibility of Candida albicans.
Watamoto T; Samaranayake LP; Jayatilake JA; Egusa H; Yatani H; Seneviratne CJ
Int J Antimicrob Agents; 2009 Oct; 34(4):333-9. PubMed ID: 19376687
[TBL] [Abstract][Full Text] [Related]
7. Novel properties of Hippophae rhamnoides L. twig and leaf extracts - anti-virulence action and synergy with antifungals studied in vitro on Candida spp. model.
Sadowska B; Budzyńska A; Stochmal A; Żuchowski J; Różalska B
Microb Pathog; 2017 Jun; 107():372-379. PubMed ID: 28428132
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of Candida albicans biofilm formation and yeast-hyphal transition by 4-hydroxycordoin.
Messier C; Epifano F; Genovese S; Grenier D
Phytomedicine; 2011 Mar; 18(5):380-3. PubMed ID: 21353508
[TBL] [Abstract][Full Text] [Related]
9. Terpenoids of plant origin inhibit morphogenesis, adhesion, and biofilm formation by Candida albicans.
Raut JS; Shinde RB; Chauhan NM; Karuppayil SM
Biofouling; 2013; 29(1):87-96. PubMed ID: 23216018
[TBL] [Abstract][Full Text] [Related]
10. Dracorhodin perchlorate inhibits biofilm formation and virulence factors of Candida albicans.
Yang LF; Liu X; Lv LL; Ma ZM; Feng XC; Ma TH
J Mycol Med; 2018 Mar; 28(1):36-44. PubMed ID: 29477784
[TBL] [Abstract][Full Text] [Related]
11. Effects of magnolol and honokiol on adhesion, yeast-hyphal transition, and formation of biofilm by Candida albicans.
Sun L; Liao K; Wang D
PLoS One; 2015; 10(2):e0117695. PubMed ID: 25710475
[TBL] [Abstract][Full Text] [Related]
12. Non-antifungal drugs inhibit growth, morphogenesis and biofilm formation in Candida albicans.
Kathwate GH; Shinde RB; Mohan Karuppayil S
J Antibiot (Tokyo); 2021 May; 74(5):346-353. PubMed ID: 33469194
[TBL] [Abstract][Full Text] [Related]
13. Enhanced antifungal activity of voriconazole-loaded nanostructured lipid carriers against
Tian B; Yan Q; Wang J; Ding C; Sai S
Int J Nanomedicine; 2017; 12():7131-7141. PubMed ID: 29026306
[No Abstract] [Full Text] [Related]
14. A new acridone with antifungal properties against Candida spp. and dermatophytes, and antibiofilm activity against C. albicans.
de Oliveira DBC; Silva LB; da Silva BV; Borges TC; Marques BC; Dos Santos MB; de Oliveira LF; Bolzani VS; Rodrigues ARA; Regasini LO; Andrade AA
J Appl Microbiol; 2019 Nov; 127(5):1362-1372. PubMed ID: 31297951
[TBL] [Abstract][Full Text] [Related]
15. Effect of 2, 4-di-tert-butylphenol on growth and biofilm formation by an opportunistic fungus Candida albicans.
Padmavathi AR; Bakkiyaraj D; Thajuddin N; Pandian SK
Biofouling; 2015; 31(7):565-74. PubMed ID: 26299260
[TBL] [Abstract][Full Text] [Related]
16. Effect of ferrocene-substituted porphyrin RL-91 on Candida albicans biofilm formation.
Lippert R; Vojnovic S; Mitrovic A; Jux N; Ivanović-Burmazović I; Vasiljevic B; Stankovic N
Bioorg Med Chem Lett; 2014 Aug; 24(15):3506-11. PubMed ID: 24929472
[TBL] [Abstract][Full Text] [Related]
17. Thymol inhibits Candida albicans biofilm formation and mature biofilm.
Braga PC; Culici M; Alfieri M; Dal Sasso M
Int J Antimicrob Agents; 2008 May; 31(5):472-7. PubMed ID: 18329858
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of Candida albicans Biofilm Formation by the Synthetic Lactoferricin Derived Peptide hLF1-11.
Morici P; Fais R; Rizzato C; Tavanti A; Lupetti A
PLoS One; 2016; 11(11):e0167470. PubMed ID: 27902776
[TBL] [Abstract][Full Text] [Related]
19. Effect of licorice compounds licochalcone A, glabridin and glycyrrhizic acid on growth and virulence properties of Candida albicans.
Messier C; Grenier D
Mycoses; 2011 Nov; 54(6):e801-6. PubMed ID: 21615543
[TBL] [Abstract][Full Text] [Related]
20. Small-Molecule Morphogenesis Modulators Enhance the Ability of 14-Helical β-Peptides To Prevent Candida albicans Biofilm Formation.
Rodríguez López AL; Lee MR; Wang NB; Dunn KK; Sanchez H; Raman N; Andes DR; Lynn DM; Palecek SP
Antimicrob Agents Chemother; 2019 Sep; 63(9):. PubMed ID: 31209011
[No Abstract] [Full Text] [Related]
[Next] [New Search]
